Showing results (441-450 of 501) with videos related to
Sort By:
Pageof 51
JAMA Oncology|May 12, 2017
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation TherapyShuang G Zhao, S Laura Chang, Nicholas Erho, et al.European Urology|December 23, 2025
Development and Validation of a Multimodal Artificial Intelligence-derived Digital Pathology-based Biomarker Predicting Metastasis Among Patients with Biochemical Recurrence After Radical Prostatectomy in NRG/RTOG TrialsTodd M Morgan, Yi Ren, Siyi Tang, et al.Cancer Research|December 25, 2016
MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2Rajdeep Das, Philip A Gregory, Rayzel C Fernandes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2018
Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective StudyRahul Aggarwal, Jiaoti Huang, Joshi J Alumkal, et al.NEJM Evidence|February 6, 2024
Artificial Intelligence Predictive Model for Hormone Therapy Use in Prostate CancerDaniel E Spratt, Siyi Tang, Yilun Sun, et al.Nature Genetics|July 15, 2020
The DNA methylation landscape of advanced prostate cancerShuang G Zhao, William S Chen, Haolong Li, et al.JAMA Oncology|February 11, 2021
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical TrialFelix Y Feng, Huei-Chung Huang, Daniel E Spratt, et al.Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistanceJoshi J Alumkal, Duanchen Sun, Eric Lu, et al.Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.Communications Biology|June 4, 2021
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differencesWalter Rayford, Alp Tuna Beksac, Jordan Alger, et al.Pageof 51